These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6071105)

  • 1. [A simple method for the preparation of human factor VII-deficient plasma].
    Lechner K; Deutsch E
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):252-8. PubMed ID: 6071105
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of canine factor VII deficient substrate plasma.
    Gaston LW; Spivack AR
    J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood coagulation factors in preserved blood and plasma. 2].
    Vlcková M
    Vnitr Lek; 1970 Jan; 16(1):73-81. PubMed ID: 5416242
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methodological aspects for the determination of the coagulative activity of coagulation factors II, V, VII and X from dog plasma].
    Mischke R
    Zentralbl Veterinarmed A; 1994 Aug; 41(6):431-42. PubMed ID: 7863734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
    Mischke R; Deniz A; Nolte I
    Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method for factor VII deficient substrate preparation and coagulation studies in malaria.
    Rojanasthien S; Surakamollert V; Isarangkura P; Boonpucknavig S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():225-8. PubMed ID: 7886582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in coagulation factors after hepatic artery ligation in dogs.
    Bengmark S; Hafström LO; Korsan-Bengtsen K; Loughridge B
    Acta Hepatosplenol; 1970; 17(6):398-402. PubMed ID: 5212541
    [No Abstract]   [Full Text] [Related]  

  • 10. [Congenital deficiency of factor X (Stuart-Prower factor)].
    Szönyi L; Pálos T; Rentka M
    Z Kinderheilkd; 1969; 106(2):100-6. PubMed ID: 5802053
    [No Abstract]   [Full Text] [Related]  

  • 11. An assay for coagulation factor VII using factor VII-depleted bovine plasma.
    Nemerson Y; Clyne LP
    J Lab Clin Med; 1974 Feb; 83(2):301-3. PubMed ID: 4810955
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on blood coagulation factors; factor V and factor VII complex. I. Studies on the assay of factor V and factor VII complex].
    Kubo K
    Naika Hokan; 1968 Apr; 15(4):95-102. PubMed ID: 5693429
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
    Hattori T; Khan MM; Colman RW; Edmunds LH
    J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous administration of T-2 toxin on blood coagulation in calves.
    Gentry PA; Cooper ML
    Am J Vet Res; 1983 May; 44(5):741-6. PubMed ID: 6869975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of activated coagulation factor VII by normal human plasma.
    Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
    Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of prothrombin time measurements in canine plasma.
    Mischke R; Nolte I
    Am J Vet Res; 1997 Mar; 58(3):236-41. PubMed ID: 9055967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of coagulation factors II, V, VII and X in healthy dogs--dependence on age, sex and breed].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1994 Sep; 107(9):289-94. PubMed ID: 7980377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FUNCTIONAL RELATION BETWEEN ERYTHROPLASTIN (ERYTHROCYTE COAGULANT FACTOR) AND PLASMA FACTORS: PROACCELERIN (V), PROCONVERTIN (VII) AND STUART FACTOR(X)].
    GAERTNER H; CAEN J
    Acta Physiol Pol; 1964; 15():237-43. PubMed ID: 14227143
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequencies of mild factor V, VII and X deficiencies in a Japanese population.
    Yasunaga C; Suehisa E; Toku M; Kawasaki T; Hidaka Y
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):597-600. PubMed ID: 18685445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.